Malin Nittve
General Counsel bei EGETIS THERAPEUTICS AB
Ursprung des Netzwerks ersten Grades von Malin Nittve
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Malin Nittve
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree | |
| NEOS AB | Medical Specialties | Chairman Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Biotechnology | Founder Chief Executive Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Public Communications Contact Investor Relations Contact | |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director of Finance/CFO General Counsel | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Avidicare AB
 Avidicare AB Medical DistributorsDistribution Services Avidicare AB operates as a medical device company. It specializes in the management of airborne bacteria and virus pollution at hospitals. The firm provides Opragon, a ventilation system for reduction of airborne bacterial contamination in various hospital environments primarily for infection sensitive surgery. The company offers Opragon for preparation rooms, operating theaters, and hybrid rooms; and air curtains and external air showers. Avidicare was founded in 2010 and is headquartered in Lund, Sweden. | Medical Distributors | Director/Board Member | |
| Mahshid Advisors AB | Director/Board Member | ||
| Venaticus Capital AB | Director/Board Member | ||
| The European Medicines Agency | National Agency | Director/Board Member | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Comptroller/Controller/Auditor | |
Pareto Securities AB
 Pareto Securities AB Investment Banks/BrokersFinance Pareto Securities AB is the Swedish brokerage subsidiary of Pareto Securities AS, itself a subsidiary of Pareto AS in Norway. Headquartered in Stockholm, the firm provides full spectrum of brokerage services specifically tailored for both retail and institutional investors. They has expertise in Nordic capital markets and a strong international presence within the oil, offshore, shipping and natural resources sectors. | Investment Banks/Brokers | Analyst-Equity | |
| NANEXA AB | Medical Specialties | Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member | |
| Navigation Dynamics AB | Director/Board Member | ||
| ADDLIFE AB | Medical/Nursing Services | Director/Board Member | |
| Parke-Davis AB | Chief Tech/Sci/R&D Officer | ||
| Astra Research Centre AB | Chief Tech/Sci/R&D Officer | ||
| EXINI DIAGNOSTICS AB | Packaged Software | Director/Board Member | |
| Jettesta AB | Director/Board Member | ||
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| Wingfirm Pharma AB | Director/Board Member | ||
| NICOX SA | Pharmaceuticals: Major | Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
| ANALYTICA | Medical Specialties | Director/Board Member | |
| Läkemedelsverket | Corporate Officer/Principal | ||
| BIOGAIA AB | Pharmaceuticals: Other | Compliance Officer | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chairman |
Statistik
International
| Schweden | 38 |
| Frankreich | 5 |
| Vereinigtes Königreich | 3 |
| Australien | 3 |
| Dänemark | 3 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 6 |
| Finance | 5 |
| Commercial Services | 3 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 81 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 21 |
| Chairman | 16 |
| Chief Executive Officer | 14 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Malin Nittve
- Unternehmensverbindungen
